clinical trial · NCT06194461
LTFU for All Cell and Gene Therapy Studies
AstraZeneca·—·not yet recruiting·n = 64
Hepatocellular CarcinomaProstate CancerAZD5851AZD0754
brief summary
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
started
Sep 17, 2025
primary completion
Nov 29, 2041
completion
Nov 29, 2041
last updated
Jun 27, 2025
detailed description
This is a multi-centre and multinational basket study that will monitor the long-term safety and tolerability of cell or gene therapies in participants that have taken part in other AstraZeneca cell or gene therapy studies for up to 15 years.
official title
A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol